Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland, that develops vaccines to counter serious infectious diseases. From Wikipedia
The approval restricts use to seniors and high-risk individuals, with mandated safety studies and significant financial implications for Novavax.
